FDA Inspection
Inopak LtdInopak Ltd – FDA Inspection, Jun 18, 2021
Record Details
This FDA Inspection record concerns Inopak Ltd, with an inspection on June 18, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Inopak Ltd
- Inspection Date
- June 18, 2021
- Product Type
- Drugs
View Company Profile
ID · 57c49b30-8d0c-4e9b-aa36-7303934a6506
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1144199
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.84(b)Representative Samples
- 21 CFR 211.42(c)(2)Rejected Material Area
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Inopak Ltd
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 3, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 20, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 11, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Inopak Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.